CORD-19:2008f024274c53b0de1276f4047a6a641813fd98 / 626265-626390 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"T22826","span":{"begin":0,"end":125},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The primary efficacy endpoint was the change from baseline in Total Symptom Severity Complex (TSSC) score at 12 hr post-dose."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T360","span":{"begin":0,"end":125},"obj":"Sentence"}],"text":"The primary efficacy endpoint was the change from baseline in Total Symptom Severity Complex (TSSC) score at 12 hr post-dose."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T5860","span":{"begin":30,"end":33},"obj":"Disease"}],"attributes":[{"id":"A5860","pred":"mondo_id","subj":"T5860","obj":"http://purl.obolibrary.org/obo/MONDO_0010518"}],"text":"The primary efficacy endpoint was the change from baseline in Total Symptom Severity Complex (TSSC) score at 12 hr post-dose."}